📰 Fred Schwarzer News
Fred Schwarzer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fred Schwarzer. Real-time updates on events, politics, business and more.
May 29, 2024
MOUNTAIN VIEW, Calif., May 29, 2024 -- IGM Biosciences, Inc. , a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief...
May 28, 2024
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) fell 4.7% during trading on Tuesday . The stock traded as low as $8.98 and last traded at $9.10. 88,139 shares changed hands during trading, a decline of 72% from the average session volume of 310,274 shares. The stock had previously closed at $9.55. Wall […]
May 27, 2024
HC Wainwright reissued their neutral rating on shares of IGM Biosciences (NASDAQ:IGMS – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $12.00 target price on the stock. Other research analysts have also recently issued research reports about the company. Wedbush reiterated an outperform rating and issued a […]
May 6, 2024
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $10.07, but opened at $9.85. IGM Biosciences shares last traded at $9.94, with a volume of 15,541 shares changing hands. Wall Street Analyst Weigh In IGMS has been the subject of a […]
April 18, 2024
IGM Biosciences (NASDAQ:IGMS – Get Free Report)‘s stock had its “neutral” rating reissued by equities researchers at HC Wainwright in a report released on Thursday, Benzinga reports. They presently have a $12.00 price target on the stock. HC Wainwright’s price objective suggests a potential upside of 47.60% from the company’s current price. Separately, Royal Bank […]
April 10, 2024
MOUNTAIN VIEW, Calif., April 10, 2024 -- IGM Biosciences, Inc. , a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief...
April 5, 2024
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 4,760,000 shares, an increase of 5.5% from the February 29th total of 4,510,000 shares. Based on an average daily volume of 291,100 shares, […]
March 25, 2024
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) traded down 6.7% on Monday . The company traded as low as $9.57 and last traded at $9.60. 97,494 shares changed hands during mid-day trading, a decline of 66% from the average session volume of 286,859 shares. The stock had previously closed at $10.29. Wall […]
March 25, 2024
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) fell 6.7% on Monday . The stock traded as low as $9.57 and last traded at $9.60. 97,494 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 286,859 shares. The stock had previously closed at $10.29. Analysts Set […]
February 21, 2024
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price was down 6% during trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. Approximately 40,803 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 310,863 shares. The stock had previously closed […]